TABLE I.
Components | Evidence | Primary cell data | Tissue data |
---|---|---|---|
Classical pathway | |||
| |||
C1q | Not expressedE1 | ||
| |||
C1r | mRNAE2–E5 | Zhou et alE2 | |
ProteinE6 | |||
| |||
C1s | mRNAE3,E7 | ||
ProteinE6 | |||
| |||
C4 | mRNAE8–E10 | Scheetz et alE9 | |
ProteinE6 | Walters et alE10 | ||
SupernatantE11,E12 | Peters-Hall et alE11 | ||
Brass et alE12 | |||
| |||
C2* | mRNAE8 | ||
| |||
Lectin pathway | |||
| |||
MBL | mRNAE5,E13 | Vandermeer et alE13 | |
| |||
H-ficolin | mRNAE14 | Akaiwa et alE14 | |
ProteinE14,E15 | |||
| |||
Alternative pathway | |||
| |||
C3 | mRNAE7,E8,E16–E18 | Ali et alE20 | Schlosser et alE17 |
ProteinE6,E18,E19 | Pillai et alE21 | Lane et alE18 | |
SupernatantE1,E16,E20,E21 | |||
| |||
Factor B | mRNAE8,E13,E16,E17,E22 | Peters-Hall et alE11 | Vandermeer et alE13 |
ProteinE6 | Brass et alE12 | Schlosser et alE17 | |
SupernatantE11,E12,E16,E21 | Pillai et alE21 | ||
Cooper et alE22 | |||
| |||
Factor D | No data and not expected to occur (primary source: adipocytes) | ||
| |||
Properdin* | mRNAE13,E18,E23 | Vandermeer et alE13 | |
Lane et alE18 | |||
| |||
Terminal complement complex | |||
| |||
C5 | mRNAE7,E8,E17 | SupernatantE24 | |
ProteinE6 | |||
Schlosser et alE17 | |||
| |||
C6, C7, C8, C9* | mRNAE6,E17,E25 | Schlosser et alE17 | |
ProteinE6 | Ying et alE25 | ||
| |||
Regulators, fluid phase | |||
| |||
C1INH | No data | ||
| |||
C4BP* | SupernatantE26,E27 | ||
| |||
Factor H | mRNAE13,E28 | Pillai et alE21 | Vandermeer et alE13 |
ProteinE6 | |||
SupernatantE21,E28 | |||
| |||
Factor I | mRNAE13 | ||
ProteinE6 | |||
SupernatantE21,E26 | |||
| |||
Clusterin | mRNAE5,E29 | Peters-Hall et alE11 | |
SupernatantE11 | Hackett et alE29 | ||
| |||
Regulators, membrane bound | |||
| |||
CD46 (MCP) | mRNAE26,E30 | Suzuki et alE32 | |
ProteinE1,E31–E33 | Varsano et alE33 | ||
| |||
CD55 (DAF) | mRNAE34–E37 | Agrawal et alE34 | Suzuki et alE32 |
ProteinE1,E32,E33,E35,E37 | Pandya et alE35 | Varsano et alE33 | |
Supernatant (shedding)E36 | Vainer et alE37 | ||
| |||
CD59 | mRNAE4,E38 | Brass et alE12 | Varsano et alE33 |
ProteinE1,E33,E39 | Ali et alE20 | ||
Supernatant (shedding/exosomes)E12,E20,E40 | Castillon et alE39 | ||
Kesimer et alE40 | |||
| |||
Receptors | |||
| |||
C3aR1 | mRNAE41 | Drouin et alE41 | Drouin et alE41 |
ProteinE41–E43 | Fregonese et alE42 | ||
| |||
C5aR1 | mRNAE29,E41 | Hackett et alE29 | Gu et alE43 |
ProteinE41–E43 | Drouin et alE41 | ||
| |||
C5aR2 | No data | ||
| |||
CR1 (CD35) | Not expressedE33 |
Components that are not expressed or have no data supporting their production by airway epithelial cells are indicated by italics in the Evidence column. Evidence for protein content was based on immunoblotting, flow cytometry, or mass spectrometry of the cells/cell lysate. Supernatant denotes that the cells secreted the protein, unless otherwise specified (in which case it was either shed or secreted as exosomes).
C1INH, C1-inhibitor; C4BP, C4b-binding protein; DAF, decay-accelerating factor; MBL, mannose-binding lectin; MCP, membrane cofactor protein.
Studies from a single research group or conflicting evidence existing in the literature.